Quanterix to Launch High-Sensitivity Benchtop Instrument and Assays for Multiplex Biomarker Detection

Boston, MA and Washington D.C. – August 15, 2017 -- Quanterix Corporation, a company dedicated to digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it will be expanding its single molecule array, or Simoa, technology platform portfolio to include the new Quanterix SR-Plex benchtop instrument. In the same way that the fully automated HD-1 Analyzer offers detection and measurement of biomarkers with unprecedented sensitivity, the SR-Plex will use single molecule measurements to assess previously undetectable proteins and can significantly reduce sample volume requirements when compared to alternative approaches, all in a benchtop format that can be easily integrated with existing automation platforms. The new platform will also be capable of measuring nucleic acids with ultra-sensitivity, without utilizing polymerase chain reaction (PCR). The first unveiling of the SR-Plex will happen today at the Next Generation Dx Summit in Washington, D.C.

“We are delivering platforms at the...